Avaliação da N-acetilcisteína sobre os parâmetros comportamentais e oxidativos frente à administração a longo prazo de aspartame

Detalhes bibliográficos
Autor(a) principal: Bressan, Caroline Azzolin
Data de Publicação: 2018
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional Manancial UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/20451
Resumo: Aspartame is a synthetic sweetener widely used by individuals with restriction diets of sucrose, glucose or fructose or by those seeking wight loss. Several studies have indicated that its use is related to changes in the central nervous system, as well as to the induction of oxidative stress. However, the mechanisms responsible for such effects are not fully understood, as well as the potential of antioxidant compounds, such as N-acetylcysteine, in mitigating such damages. Thus, this study evaluated the effects of N-acetylcysteine (NAC) (163 mg/kg, i.p) on behavioral and oxidative parameters against the long-term (90 days) administration of aspartame (80 mg/kg, v.o) in brain regions of mice. For this purpose, Swiss albino male mice were divided in three groups: control – received both aspartame and Nacetylcysteine vehicles; ASP – received aspartame, and the N-acetylcysteine vehicle; and ASP-NAC – received both treatments, aspartame and N-acetylcysteine. Aspartame was administered for 90 days, while NAC was injected only in the last 30 days. In the last week of the experimental period, the animals had their behavior evaluated through the open field test. At the end of the 90 days, the animals were anesthetized and euthanized for the removal of the brain and separation of the following regions: cerebral cortex, hippocampus and cerebellum, in which was held the research of the oxidative stress biomarkers and the gene expression of catalytic subunit of glutamate cysteine ligase (Gclc), cystathionin γ-lyase (Cth) and thioredoxin 1 (Trx1). The results showed that the mice treated with aspartame and NAC presented a decrease in the number of crossings and an increase in the time spent in the central area in relation to the control animals and treated with aspartame alone. Although it did not alter the thioredoxin system, the administration of aspartame caused severe depletion in non-protein thiois (NPSH) levels as well as glutathione peroxidase (GPx) activity. Both changes were restored by treatment with NAC. Aspartame also triggered a decrease in Gclc and Cth mRNA levels. Treatment with NAC restored Gclc levels. It is concluded from these results that, although it did not alter the thioredoxin system, treatment with aspartame caused a severe depletion of NPSH levels, which may be due to the decrease in Gclc and Cth mRNA levels, demonstrating that the mechanism of action of aspartame toxicity is more related to the GSH system. In addition, the results suggest an anxiolytic effect of NAC in animals treated with aspartame. NAC was able to restore most of the changes in the GSH-related system in brain regions after long-term ingestion of aspartame.
id UFSM-20_c01ae1ff2cc84a8fc6ffab3469234a68
oai_identifier_str oai:repositorio.ufsm.br:1/20451
network_acronym_str UFSM-20
network_name_str Repositório Institucional Manancial UFSM
repository_id_str 3913
spelling 2021-03-18T11:18:11Z2021-03-18T11:18:11Z2018-01-31http://repositorio.ufsm.br/handle/1/20451Aspartame is a synthetic sweetener widely used by individuals with restriction diets of sucrose, glucose or fructose or by those seeking wight loss. Several studies have indicated that its use is related to changes in the central nervous system, as well as to the induction of oxidative stress. However, the mechanisms responsible for such effects are not fully understood, as well as the potential of antioxidant compounds, such as N-acetylcysteine, in mitigating such damages. Thus, this study evaluated the effects of N-acetylcysteine (NAC) (163 mg/kg, i.p) on behavioral and oxidative parameters against the long-term (90 days) administration of aspartame (80 mg/kg, v.o) in brain regions of mice. For this purpose, Swiss albino male mice were divided in three groups: control – received both aspartame and Nacetylcysteine vehicles; ASP – received aspartame, and the N-acetylcysteine vehicle; and ASP-NAC – received both treatments, aspartame and N-acetylcysteine. Aspartame was administered for 90 days, while NAC was injected only in the last 30 days. In the last week of the experimental period, the animals had their behavior evaluated through the open field test. At the end of the 90 days, the animals were anesthetized and euthanized for the removal of the brain and separation of the following regions: cerebral cortex, hippocampus and cerebellum, in which was held the research of the oxidative stress biomarkers and the gene expression of catalytic subunit of glutamate cysteine ligase (Gclc), cystathionin γ-lyase (Cth) and thioredoxin 1 (Trx1). The results showed that the mice treated with aspartame and NAC presented a decrease in the number of crossings and an increase in the time spent in the central area in relation to the control animals and treated with aspartame alone. Although it did not alter the thioredoxin system, the administration of aspartame caused severe depletion in non-protein thiois (NPSH) levels as well as glutathione peroxidase (GPx) activity. Both changes were restored by treatment with NAC. Aspartame also triggered a decrease in Gclc and Cth mRNA levels. Treatment with NAC restored Gclc levels. It is concluded from these results that, although it did not alter the thioredoxin system, treatment with aspartame caused a severe depletion of NPSH levels, which may be due to the decrease in Gclc and Cth mRNA levels, demonstrating that the mechanism of action of aspartame toxicity is more related to the GSH system. In addition, the results suggest an anxiolytic effect of NAC in animals treated with aspartame. NAC was able to restore most of the changes in the GSH-related system in brain regions after long-term ingestion of aspartame.O aspartame é um edulcorante sintético amplamente utilizado por indivíduos com dietas de restrição de sacarose, glicose ou frutose ou por aqueles que buscam a perda de peso. Muitos estudos têm indicado que seu uso está relacionado com alterações a nível do sistema nervoso central, bem como com a indução de estresse oxidativo. No entanto, os mecanismos responsáveis para tais efeitos não estão totalmente esclarecidos, bem como o potencial de compostos antioxidantes, tais como a N-acetilcisteína, em amenizar esses danos. Assim, este estudo avaliou os efeitos da N-acetilcisteína (NAC) (163 mg/kg, i.p.) sobre parâmetros comportamentais e oxidativos frente a administração a longo prazo (90 dias) de aspartame (80 mg/kg, v.o.) em regiões cerebrais de camundongos. Para tanto, camundongos Swiss albinos machos foram divididos em três grupos: controle – receberam ambos veículos, o do aspartame e o da N-acetilcisteína; ASP – receberam o aspartame, e o veículo da N-acetilcisteína; e ASPNAC – receberam ambos tratamentos, aspartame e N-acetilcisteína. O aspartame foi administrado durante 90 dias, enquanto a NAC foi injetada apenas nos últimos 30 dias. Na última semana do período experimental, os animais tiveram seu comportamento avaliado através do teste de campo aberto. Ao fim dos 90 dias, os animais foram anestesiados e eutanasiados para a remoção do encéfalo e separação das seguintes regiões: córtex cerebral, hipocampo e cerebelo, nas quais foi realizada a pesquisa por biomarcadores de estresse oxidativo e a expressão gênica da subunidade catalítica da glutamato cisteína ligase (Gclc), da cistationina γ-liase (Cth) e da tiorredoxina 1 (Trx1). Os resultados obtidos demonstraram que os camundongos tratados com aspartame e NAC apresentaram uma diminuição no número de crossings e um aumento no tempo gasto na área central em relação aos animais do controle e tratados somente com aspartame. Apesar de não ter alterado o sistema da tioredoxina, a administração de aspartame causou uma severa depleção nos níveis de tiois não proteicos, assim como na atividade da glutationa peroxidase. Ambas alterações foram restauradas pelo tratamento com a NAC. O aspartame também desencadeou uma diminuição nos níveis de mRNA da Gclc e da Cth e o tratamento com a NAC restaurou os níveis de Gclc. Conclui-se a partir destes resultados que, apesar de não ter alterado o sistema da tiorredoxina, o tratamento com aspartame causou uma severa depleção dos níveis de GSH, o que pode ser devido a diminuição dos níveis de mRNA da Gclc e da Cth, demonstrando que o mecanismo de ação da toxicidade do aspartame está mais relacionado ao sistema da GSH. Além disso, os resultados sugerem um efeito ansiolítico da NAC em animais tratados com aspartame. A NAC foi capaz de restaurar a maioria das alterações no sistema relacionado a GSH em regiões cerebrais após a ingestão a longo prazo de aspartame.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESporUniversidade Federal de Santa MariaCentro de Ciências da SaúdePrograma de Pós-Graduação em FarmacologiaUFSMBrasilFarmacologiaAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessGlutationaAdoçantes de baixa caloriaTiorredoxinaRegiões cerebraisGlutathioneLow-calorie sweetenersTioredoxinBrain regionsCNPQ::CIENCIAS DA SAUDE::FARMACIAAvaliação da N-acetilcisteína sobre os parâmetros comportamentais e oxidativos frente à administração a longo prazo de aspartameN-acetylcysteine evaluation on behavioral and oxidative parameters front long term administration of aspartameinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisPavanato, Maria Amáliahttp://lattes.cnpq.br/8701892865724171Machado, Alencar Kolinskihttp://lattes.cnpq.br/7339960872140748Bochi, Guilherme Vargashttp://lattes.cnpq.br/4191221572795869http://lattes.cnpq.br/3810485632511405Bressan, Caroline Azzolin4003000000056007d7838b4-f884-4ada-a8a9-eb44cdaac1befeca3620-44a2-42ee-a96a-c55e893aab37a0fb3c5d-bcef-417c-8c06-73d8f207ab8c1c7110ce-ab6f-4049-a510-6896d577a65freponame:Repositório Institucional Manancial UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMORIGINALDIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdfDIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdfDissertação de Mestradoapplication/pdf2034387http://repositorio.ufsm.br/bitstream/1/20451/1/DIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdf26ed6c455ab0ac510a39e2c273e2e2a7MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.ufsm.br/bitstream/1/20451/2/license_rdf4460e5956bc1d1639be9ae6146a50347MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81956http://repositorio.ufsm.br/bitstream/1/20451/3/license.txt2f0571ecee68693bd5cd3f17c1e075dfMD53TEXTDIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdf.txtDIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdf.txtExtracted texttext/plain108725http://repositorio.ufsm.br/bitstream/1/20451/4/DIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdf.txt5a4ef7cf283952df2405ca4e93c0d581MD54THUMBNAILDIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdf.jpgDIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdf.jpgIM Thumbnailimage/jpeg2920http://repositorio.ufsm.br/bitstream/1/20451/5/DIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdf.jpgd948ee58e8a9f3ceacfb8230c0d35a55MD551/204512021-03-19 03:01:29.905oai:repositorio.ufsm.br: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ório Institucionalhttp://repositorio.ufsm.br/PUBhttp://repositorio.ufsm.br/oai/requestouvidoria@ufsm.bropendoar:39132021-03-19T06:01:29Repositório Institucional Manancial UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.por.fl_str_mv Avaliação da N-acetilcisteína sobre os parâmetros comportamentais e oxidativos frente à administração a longo prazo de aspartame
dc.title.alternative.eng.fl_str_mv N-acetylcysteine evaluation on behavioral and oxidative parameters front long term administration of aspartame
title Avaliação da N-acetilcisteína sobre os parâmetros comportamentais e oxidativos frente à administração a longo prazo de aspartame
spellingShingle Avaliação da N-acetilcisteína sobre os parâmetros comportamentais e oxidativos frente à administração a longo prazo de aspartame
Bressan, Caroline Azzolin
Glutationa
Adoçantes de baixa caloria
Tiorredoxina
Regiões cerebrais
Glutathione
Low-calorie sweeteners
Tioredoxin
Brain regions
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Avaliação da N-acetilcisteína sobre os parâmetros comportamentais e oxidativos frente à administração a longo prazo de aspartame
title_full Avaliação da N-acetilcisteína sobre os parâmetros comportamentais e oxidativos frente à administração a longo prazo de aspartame
title_fullStr Avaliação da N-acetilcisteína sobre os parâmetros comportamentais e oxidativos frente à administração a longo prazo de aspartame
title_full_unstemmed Avaliação da N-acetilcisteína sobre os parâmetros comportamentais e oxidativos frente à administração a longo prazo de aspartame
title_sort Avaliação da N-acetilcisteína sobre os parâmetros comportamentais e oxidativos frente à administração a longo prazo de aspartame
author Bressan, Caroline Azzolin
author_facet Bressan, Caroline Azzolin
author_role author
dc.contributor.advisor1.fl_str_mv Pavanato, Maria Amália
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/8701892865724171
dc.contributor.referee1.fl_str_mv Machado, Alencar Kolinski
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/7339960872140748
dc.contributor.referee2.fl_str_mv Bochi, Guilherme Vargas
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/4191221572795869
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/3810485632511405
dc.contributor.author.fl_str_mv Bressan, Caroline Azzolin
contributor_str_mv Pavanato, Maria Amália
Machado, Alencar Kolinski
Bochi, Guilherme Vargas
dc.subject.por.fl_str_mv Glutationa
Adoçantes de baixa caloria
Tiorredoxina
Regiões cerebrais
topic Glutationa
Adoçantes de baixa caloria
Tiorredoxina
Regiões cerebrais
Glutathione
Low-calorie sweeteners
Tioredoxin
Brain regions
CNPQ::CIENCIAS DA SAUDE::FARMACIA
dc.subject.eng.fl_str_mv Glutathione
Low-calorie sweeteners
Tioredoxin
Brain regions
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS DA SAUDE::FARMACIA
description Aspartame is a synthetic sweetener widely used by individuals with restriction diets of sucrose, glucose or fructose or by those seeking wight loss. Several studies have indicated that its use is related to changes in the central nervous system, as well as to the induction of oxidative stress. However, the mechanisms responsible for such effects are not fully understood, as well as the potential of antioxidant compounds, such as N-acetylcysteine, in mitigating such damages. Thus, this study evaluated the effects of N-acetylcysteine (NAC) (163 mg/kg, i.p) on behavioral and oxidative parameters against the long-term (90 days) administration of aspartame (80 mg/kg, v.o) in brain regions of mice. For this purpose, Swiss albino male mice were divided in three groups: control – received both aspartame and Nacetylcysteine vehicles; ASP – received aspartame, and the N-acetylcysteine vehicle; and ASP-NAC – received both treatments, aspartame and N-acetylcysteine. Aspartame was administered for 90 days, while NAC was injected only in the last 30 days. In the last week of the experimental period, the animals had their behavior evaluated through the open field test. At the end of the 90 days, the animals were anesthetized and euthanized for the removal of the brain and separation of the following regions: cerebral cortex, hippocampus and cerebellum, in which was held the research of the oxidative stress biomarkers and the gene expression of catalytic subunit of glutamate cysteine ligase (Gclc), cystathionin γ-lyase (Cth) and thioredoxin 1 (Trx1). The results showed that the mice treated with aspartame and NAC presented a decrease in the number of crossings and an increase in the time spent in the central area in relation to the control animals and treated with aspartame alone. Although it did not alter the thioredoxin system, the administration of aspartame caused severe depletion in non-protein thiois (NPSH) levels as well as glutathione peroxidase (GPx) activity. Both changes were restored by treatment with NAC. Aspartame also triggered a decrease in Gclc and Cth mRNA levels. Treatment with NAC restored Gclc levels. It is concluded from these results that, although it did not alter the thioredoxin system, treatment with aspartame caused a severe depletion of NPSH levels, which may be due to the decrease in Gclc and Cth mRNA levels, demonstrating that the mechanism of action of aspartame toxicity is more related to the GSH system. In addition, the results suggest an anxiolytic effect of NAC in animals treated with aspartame. NAC was able to restore most of the changes in the GSH-related system in brain regions after long-term ingestion of aspartame.
publishDate 2018
dc.date.issued.fl_str_mv 2018-01-31
dc.date.accessioned.fl_str_mv 2021-03-18T11:18:11Z
dc.date.available.fl_str_mv 2021-03-18T11:18:11Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/20451
url http://repositorio.ufsm.br/handle/1/20451
dc.language.iso.fl_str_mv por
language por
dc.relation.cnpq.fl_str_mv 400300000005
dc.relation.confidence.fl_str_mv 600
dc.relation.authority.fl_str_mv 7d7838b4-f884-4ada-a8a9-eb44cdaac1be
feca3620-44a2-42ee-a96a-c55e893aab37
a0fb3c5d-bcef-417c-8c06-73d8f207ab8c
1c7110ce-ab6f-4049-a510-6896d577a65f
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Farmacologia
dc.publisher.initials.fl_str_mv UFSM
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Farmacologia
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Repositório Institucional Manancial UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Repositório Institucional Manancial UFSM
collection Repositório Institucional Manancial UFSM
bitstream.url.fl_str_mv http://repositorio.ufsm.br/bitstream/1/20451/1/DIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdf
http://repositorio.ufsm.br/bitstream/1/20451/2/license_rdf
http://repositorio.ufsm.br/bitstream/1/20451/3/license.txt
http://repositorio.ufsm.br/bitstream/1/20451/4/DIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdf.txt
http://repositorio.ufsm.br/bitstream/1/20451/5/DIS_PPGFARMACOLOGIA_2018_BRESSAN_CAROLINE.pdf.jpg
bitstream.checksum.fl_str_mv 26ed6c455ab0ac510a39e2c273e2e2a7
4460e5956bc1d1639be9ae6146a50347
2f0571ecee68693bd5cd3f17c1e075df
5a4ef7cf283952df2405ca4e93c0d581
d948ee58e8a9f3ceacfb8230c0d35a55
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional Manancial UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv ouvidoria@ufsm.br
_version_ 1808854689592115200